CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Depleting regulatory T cells (T reg cells) to counteract immunosuppressive features of the tumor microenvironment (TME) is an attractive strategy for cancer treatment; however, autoimmunity due to systemic impairment of their suppressive function limits its therapeutic potential. Elucidating approac...
Uložené v:
| Vydané v: | Nature immunology Ročník 21; číslo 3; s. 298 - 308 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
New York
Nature Publishing Group US
01.03.2020
Nature Publishing Group |
| Predmet: | |
| ISSN: | 1529-2908, 1529-2916, 1529-2916 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | Depleting regulatory T cells (T
reg
cells) to counteract immunosuppressive features of the tumor microenvironment (TME) is an attractive strategy for cancer treatment; however, autoimmunity due to systemic impairment of their suppressive function limits its therapeutic potential. Elucidating approaches that specifically disrupt intratumoral T
reg
cells is direly needed for cancer immunotherapy. We found that CD36 was selectively upregulated in intrautumoral T
reg
cells as a central metabolic modulator. CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-β signaling, programming T
reg
cells to adapt to a lactic acid-enriched TME. Genetic ablation of
Cd36
in T
reg
cells suppressed tumor growth accompanied by a decrease in intratumoral T
reg
cells and enhancement of antitumor activity in tumor-infiltrating lymphocytes without disrupting immune homeostasis. Furthermore, CD36 targeting elicited additive antitumor responses with anti-programmed cell death protein 1 therapy. Our findings uncover the unexplored metabolic adaptation that orchestrates the survival and functions of intratumoral T
reg
cells, and the therapeutic potential of targeting this pathway for reprogramming the TME.
Tumor environments are highly acidic due to high concentrations of lactic acid. Ho and colleagues report that tumor-infiltrating regulatory T cells adapt to this tumor environment by upregulating expression of CD36, which allows them to use fatty acids to fuel their metabolism. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 1529-2908 1529-2916 1529-2916 |
| DOI: | 10.1038/s41590-019-0589-5 |